Welcome to Breakthrough Investor. You can find Matt McCall's latest research on the next page, but first, as our thank you for signing up, you may also choose any of the following bonus reports completely free of charge…
(Continue to the next page to access the special presentation)
Opening Recap Market Pulse: U.S. stocks edged within a tight band yesterday, shrugging off hawkish Fed chatter and ending largely flat. Tech names held ground
Company Overview Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (ir.gossamerbio.com).
Opening Recap Market Pulse: Equities drifted Friday with tech sagging and value names barely moving, setting a lukewarm tone. Key Movers: China’s robot-hand unicorn Linkerbot
